Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycoprotein M6B pseudogene 1 (GPM6BP1) is a human genomic locus annotated as a pseudogene, meaning it is a non-functional copy related to the gene encoding glycoprotein M6B. Pseudogenes typically do not produce functional proteins and are not known to have roles in normal physiology or disease. GPM6BP1 does not encode an active protein and is not considered a therapeutic target or receptor[4]. Key clarifications: - This entry refers to a pseudogene and is therefore not a drug target, receptor, enzyme, transporter, or similar molecule[4]. - There is no evidence for GPM6BP1 functioning in signal transduction, disease, or interaction with drugs. - If you are seeking a therapeutic target, you may want to examine the functional gene GPM6B (Glycoprotein M6B) rather than this pseudogene. Summary: GPM6BP1 is not a functional molecular target; it is a pseudogene and does not encode a biologically active protein, nor is it involved in known disease mechanisms or targeted by therapeutics[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein M6B pseudogene 1 (GPM6BP1).